Delivery Order V797P2022D-36C24519F0389

Award Date 1/25/19
Potential Completion Date 2/8/19
Potential Value $6.9K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $76,397.96 firm fixed-price contract is for the drug Adempas, which is used to treat pulmonary arterial hypertension. This contract is under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside designation. Bayer Healthcare Pharmaceuticals Inc. is the prime...
This is a firm fixed-price purchase order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth to Priority Healthcare Distribution Inc. for the supply of ADEMPAS 1MG TAB 90/BTL. The potential value of the contract is $157,587.92, with a completion date of November 28, 2022. The contract does not have a set-aside designation. As a prime contractor, Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division,...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc. The $25,831.04 order is for the delivery of 1,080 mg doses of the drug EMPAVELI to VA facilities in Pittsburgh, Pennsylvania. EMPAVELI is used to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder. The delivery order falls under APL Sales I LLC's Federal Supply...
The Department of Veterans Affairs Veterans Health Administration awarded a $25,506.96 delivery order contract to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc., to provide EMPAVELI 1080 MG. The contract was awarded under the Pharmaceuticals and Drugs GSA Schedule, also known as FSS-61-IB, and will be performed in Pittsburgh, Pennsylvania over a one week period concluding on January 4, 2024. As the parent company produces drugs to treat rare diseases, this contract is likely...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,584.53 firm fixed price delivery order contract to Actelion Pharmaceuticals US, Inc. for the provision of UPTRAVI/SELEXIPAG 1600MCG tablets. Actelion Pharmaceuticals US, Inc. will perform under the contract from its location in Titusville, New Jersey. The contract was awarded against Actelion Pharmaceuticals US, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract and will run...
The Department of Veterans Affairs Veterans Health Administration and Veterans Integrated Service Network 5 awarded a firm fixed price delivery order to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc., to provide the drug EMPAVELI to VA facilities in Pittsburgh, Pennsylvania. The $25,831.04 order had a short performance period of March 20, 2024 to March 22, 2024 to fulfill urgent needs. APL Sales I LLC is the prime contractor providing the pharmaceutical under its Federal Supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $748 to Amerisourcebergen Drug Corporation to supply 4561681080 APREPITANT 40 MG CAPSULE UD 5S. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. No major subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to provide...
This delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 is for the drug UPTRAVI 1200MCG, with a potential value of $13,765.14. The prime contractor is Actelion Pharmaceuticals US, Inc. located in Titusville, New Jersey. The contract has a firm fixed price and is for delivery of the requested pharmaceutical to the agency's facilities, with performance at...
Actelion Pharmaceuticals US, Inc. was awarded a $14,584.53 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order is for the provision of UPTRAVI/SELEXIPAG 1600MCG tablets to the agency, with performance taking place in Titusville, New Jersey. The contract has a firm fixed price and period of performance through July 2023. No...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product FYCOMPA 8 MG TABLET 30S. The contract has a ceiling value of $2,101.56 and a period of performance through August 8, 2024. The contract is a firm-fixed-price arrangement and does not utilize a socioeconomic set-aside. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is issued under a larger...

ADEMPAS 2MG TABLET

Posted 1/25/19, 12:00 AM